{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:58:31Z","timestamp":1785862711596,"version":"3.56.0"},"reference-count":28,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T00:00:00Z","timestamp":1548028800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX001060"],"award-info":[{"award-number":["I01 BX001060"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK017047"],"award-info":[{"award-number":["P30 DK017047"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32 DK107022"],"award-info":[{"award-number":["F32 DK107022"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-153156"],"award-info":[{"award-number":["PJT-153156"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"JDRF","doi-asserted-by":"publisher","award":["3-SRA-2014-39-Q-R"],"award-info":[{"award-number":["3-SRA-2014-39-Q-R"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.2337\/dci18-0054","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T01:25:56Z","timestamp":1548120356000},"page":"183-185","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":8,"title":["Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes"],"prefix":"10.2337","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-9002","authenticated-orcid":false,"given":"Steven E.","family":"Kahn","sequence":"first","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System, Seattle, WA"},{"name":"Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-9304","authenticated-orcid":false,"given":"Andrew T.","family":"Templin","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System, Seattle, WA"},{"name":"Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-4087","authenticated-orcid":false,"given":"Rebecca L.","family":"Hull","sequence":"additional","affiliation":[{"name":"Veterans Affairs Puget Sound Health Care System, Seattle, WA"},{"name":"Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[{"name":"Department of Surgery and Department of Pathology and Laboratory Medicine, BC Children's Hospital Research Institute and University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"2022031221300156300_B1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1210\/jcem-65-1-30","article-title":"Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual \u03b2-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT)","volume":"65","author":"The DCCT Research Group","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221300156300_B2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM198903023200902","article-title":"A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus","volume":"320","author":"Shah","year":"1989","journal-title":"N Engl J Med"},{"key":"2022031221300156300_B3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02629258","article-title":"Abnormal proinsulin\/C-peptide ratio in juvenile diabetes","volume":"19","author":"Ludvigsson","year":"1982","journal-title":"Acta Diabetol Lat"},{"key":"2022031221300156300_B4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diacare.19.2.146","article-title":"Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies","volume":"19","author":"Snorgaard","year":"1996","journal-title":"Diabetes Care"},{"key":"2022031221300156300_B5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-2625","article-title":"Proinsulin secretion is a persistent feature of type 1 diabetes","volume":"42","author":"Sims","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031221300156300_B6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2337\/diab.46.11.1725","article-title":"Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM","volume":"46","author":"Kahn","year":"1997","journal-title":"Diabetes"},{"key":"2022031221300156300_B7","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic \u03b2-cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"2022031221300156300_B8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/dc11-1236","article-title":"Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay","volume":"35","author":"Wang","year":"2012","journal-title":"Diabetes Care"},{"key":"2022031221300156300_B9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","article-title":"The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells","volume":"57","author":"Oram","year":"2014","journal-title":"Diabetologia"},{"key":"2022031221300156300_B10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/dc14-1952","article-title":"Prevalence of detectable C-peptide according to age at diagnosis and duration of type 1 diabetes","volume":"38","author":"Davis","year":"2015","journal-title":"Diabetes Care"},{"key":"2022031221300156300_B11","doi-asserted-by":"crossref","first-page":"e1374","DOI":"10.1371\/journal.pone.0001374","article-title":"Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus","volume":"3","author":"Klinke","year":"2008","journal-title":"PLoS One"},{"key":"2022031221300156300_B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"2022031221300156300_B13"},{"key":"2022031221300156300_B14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2010.04.001","article-title":"Etiology of type 1 diabetes","volume":"32","author":"Todd","year":"2010","journal-title":"Immunity"},{"key":"2022031221300156300_B15","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"2022031221300156300_B16","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.2337\/dc14-0961","article-title":"Impact of islet autoimmunity on the progressive \u03b2-cell functional decline in type 2 diabetes","volume":"37","author":"Brooks-Worrell","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031221300156300_B17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1367-5931(98)80033-1","article-title":"The proprotein convertases","volume":"2","author":"Steiner","year":"1998","journal-title":"Curr Opin Chem Biol"},{"key":"2022031221300156300_B18","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2016-2773","article-title":"Measurement of pro-islet amyloid polypeptide (1-48) in diabetes and islet transplants","volume":"102","author":"Courtade","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031221300156300_B19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"2022031221300156300_B20","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N Engl J Med"},{"key":"2022031221300156300_B21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/03009734.2017.1359219","article-title":"Islet amyloid in recent-onset type 1 diabetes\u2014the DiViD study","volume":"122","author":"Westermark","year":"2017","journal-title":"Ups J Med Sci"},{"key":"2022031221300156300_B22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by \u03b2-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"2022031221300156300_B23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1007\/s00125-011-2143-3","article-title":"Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets","volume":"54","author":"Aston-Mourney","year":"2011","journal-title":"Diabetologia"},{"key":"2022031221300156300_B24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/diab.38.11.1333","article-title":"Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet \u03b2-cell dysfunction?","volume":"38","author":"Porte","year":"1989","journal-title":"Diabetes"},{"key":"2022031221300156300_B25","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","article-title":"Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death","volume":"55","author":"Marzban","year":"2006","journal-title":"Diabetes"},{"key":"2022031221300156300_B26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/505612a","article-title":"Policy: NIH plans to enhance reproducibility","volume":"505","author":"Collins","year":"2014","journal-title":"Nature"},{"key":"2022031221300156300_B27","article-title":"A call for improved reporting of human islet characteristics in research articles","author":"Poitout","journal-title":"Diabetologia"},{"key":"2022031221300156300_B28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/dbi18-0055","article-title":"A call for improved reporting of human islet characteristics in research articles","volume":"68","author":"Poitout","year":"2019","journal-title":"Diabetes"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dci18-0054","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/183\/527227\/dci180054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/42\/2\/183\/527227\/dci180054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:45:03Z","timestamp":1647128703000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/42\/2\/183\/30392\/Probing-the-Meaning-of-Persistent-Propeptide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,11]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci18-0054","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]}}}